OT 21818
Alternative Names: OT-21818Latest Information Update: 06 Oct 2006
At a glance
- Originator Otsuka Pharmaceutical
- Class Non-opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies; Neuropathic pain
Most Recent Events
- 06 Oct 2006 Discontinued - Preclinical for Diabetic neuropathies in Japan (unspecified route)
- 06 Oct 2006 Discontinued - Preclinical for Neuropathic pain in Japan (unspecified route)
- 23 Mar 2003 Preclinical trials in Diabetic neuropathies in Japan (unspecified route)